These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2646088)

  • 1. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R; Chowdhury P; Rayford PL
    Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; McKay D; Yajima H; Rayford PL
    Pancreas; 1989; 4(5):550-5. PubMed ID: 2813326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.
    Konturek SJ; Tasler J; Konturek JW; Cieszkowski M; Szewczyk K; Hładij M; Anderson PS
    Gut; 1989 Jan; 30(1):110-7. PubMed ID: 2920915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs.
    Hosotani R; Chowdhury P; McKay D; Rayford PL
    Peptides; 1987; 8(6):1061-4. PubMed ID: 3441445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin in the regulation of intestinal motility and pancreatic secretion in dogs.
    Thor P; Laskiewicz J; Konturek P; Konturek SJ
    Am J Physiol; 1988 Oct; 255(4 Pt 1):G498-504. PubMed ID: 3177646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
    Konturek SJ; Bilski J; Tasler J; Cieszkowski M
    J Physiol; 1992; 451():477-89. PubMed ID: 1403819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
    Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
    Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L; Dockray GJ
    Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial peptide YY release is mediated by cholecystokinin.
    McFadden DW; Rudnicki M; Kuvshinoff B; Fischer JE
    Surg Gynecol Obstet; 1992 Aug; 175(2):145-50. PubMed ID: 1636140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK receptors in release of pancreatic polypeptide (PP) in dogs.
    Konturek SJ; Konturek P; Bielański W; Szewczyk K
    Dig Dis Sci; 1989 Jun; 34(6):849-56. PubMed ID: 2721318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural mechanisms of pancreatic polypeptide release in conscious dogs.
    Hosotani R; Chowdhury P; Huang YS; Rayford PL
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G134-7. PubMed ID: 2568754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
    Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
    Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapancreatic cholinergic nerves mediate cholecystokinin-stimulated pancreatic polypeptide release.
    Kuvshinoff BW; Brodish RJ; Fink AS; McFadden DW
    J Surg Res; 1994 May; 56(5):397-401. PubMed ID: 8170138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-364,718 on pancreatic exocrine and endocrine secretion in the rat.
    Nakamura T; Fujii M; Okabayashi Y; Tani S; Fujisawa T; Koide M; Otsuki M
    Pancreas; 1990 Mar; 5(2):216-21. PubMed ID: 1690422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H; Debas HT; Bunnett NW
    Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.